Paper16680799
Novel monocyclic and bicyclic loop mimetics of brain-derived neurotrophic factor.
Fletcher JM and 1 other. J Pept Sci, 2006. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Novel monocyclic and bicyclic loop mimetics of brain-derived neurotrophic factor. Papers, record 16680799. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16680799
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomimetics | Major topic |
| Brain-Derived Neurotrophic Factor | Major topic |
| Peptides | Major topic |
| Amino Acid Sequence | |
| Analysis of Variance | |
| Animals | |
| Cell Survival | |
| Cells, Cultured | |
| Chick Embryo | |
| Dimerization | |
| Ganglia, Spinal | |
| Models, Chemical | |
| Models, Molecular | |
| Neurons, Afferent | |
| Protein Binding | |
| Protein Structure, Quaternary |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42723246 | A De Novo Peptide That Induces Axonal Growth Through TrkB Activation. | Chembiochem | 2026 | https://conductscience.org/library/papers/42723246 | PubMed |
| 38638624 | Modification of a Selective NTRK2 Agonist and Confirmation of Activity in a Glaucoma-on-a-Chip Model. | J Ophthalmic Vis Res | 2024 | https://conductscience.org/library/papers/38638624 | PubMed |
| 37488840 | Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor? | Neural Regen Res | 2024 | https://conductscience.org/library/papers/37488840 | PubMed |
| 36346920 | Neurotrophic Activity and Its Modulation by Zinc Ion of a Dimeric Peptide Mimicking the Brain-Derived Neurotrophic Factor N-Terminal Region. | ACS Chem Neurosci | 2022 | https://conductscience.org/library/papers/36346920 | PubMed |
| 33833366 | Dimeric mimetic of BDNF loop 4 promotes survival of serum-deprived cell through TrkB-dependent apoptosis suppression. | Sci Rep | 2021 | https://conductscience.org/library/papers/33833366 | PubMed |
| 30211565 | Supramolecular Nanostructure Activates TrkB Receptor Signaling of Neuronal Cells by Mimicking Brain-Derived Neurotrophic Factor. | Nano Lett | 2018 | https://conductscience.org/library/papers/30211565 | PubMed |
| 27400746 | Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease. | Mol Neurodegener | 2016 | https://conductscience.org/library/papers/27400746 | PubMed |
| 26740873 | 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. | Transl Neurodegener | 2016 | https://conductscience.org/library/papers/26740873 | PubMed |
| 24609976 | Neurotrophin strategies for neuroprotection: are they sufficient? | J Neuroimmune Pharmacol | 2014 | https://conductscience.org/library/papers/24609976 | PubMed |
| 24300402 | From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). | Pharmaceutics | 2013 | https://conductscience.org/library/papers/24300402 | PubMed |
| 24243532 | Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. | Curr Psychiatry Rep | 2013 | https://conductscience.org/library/papers/24243532 | PubMed |
| 23975404 | Brain-derived neurotrophic factor loop 4 dipeptide mimetic GSB-106 activates TrkB, Erk, and Akt and promotes neuronal survival in vitro. | Dokl Biochem Biophys | 2013 | https://conductscience.org/library/papers/23975404 | PubMed |
| 23674053 | BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. | Nat Rev Neurosci | 2013 | https://conductscience.org/library/papers/23674053 | PubMed |
| 23670594 | TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders. | Int J Mol Sci | 2013 | https://conductscience.org/library/papers/23670594 | PubMed |
| 22848172 | Peptide-mediated targeting of liposomes to TrkB receptor-expressing cells. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/22848172 | PubMed |
| 20644624 | Deoxygedunin, a natural product with potent neurotrophic activity in mice. | PLoS One | 2010 | https://conductscience.org/library/papers/20644624 | PubMed |
| 20407211 | Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20407211 | PubMed |
| 20133810 | A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133810 | PubMed |
| 19903142 | Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents. | Curr Med Chem | 2009 | https://conductscience.org/library/papers/19903142 | PubMed |
| 18809686 | Design of a conformationally defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18809686 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16680799
GET https://conductscience.org/api/papers/v1/16680799/authors